SF3B1 mutation as a predictive biomarker for luspatercept efficacy in myeloproliferative neoplasms and MDS/MPN: a clinical study

Annals of Hematology 2026 Open access

Read full text

Authors: Tingting Cui, Jie Gong, Xinyu Zhang, Juan Zhang, Na Wei, Wenqi Zheng, Duan Minghui

DOI: 10.1007/s00277-026-06804-9

Cited by: 0

References: 12

Fields of Study & Subjects

Acute Myeloid Leukemia Research Myeloproliferative Neoplasms: Diagnosis and Treatment Retinoids in leukemia and cellular processes

References 12